Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin
Open Access
- 21 January 2013
- Vol. 5 (1), 352-373
- https://doi.org/10.3390/v5010352
Abstract
Influenza A virus (IAV) has caused seasonal influenza epidemics and influenza pandemics, which resulted in serious threat to public health and socioeconomic impacts. Until now, only 5 drugs belong to two categories are used for prophylaxis and treatment of IAV infection. Hemagglutinin (HA), the envelope glycoprotein of IAV, plays a critical role in viral binding, fusion and entry. Therefore, HA is an attractive target for developing anti‑IAV drugs to block the entry step of IAV infection. Here we reviewed the recent progress in the study of conformational changes of HA during viral fusion process and the development of HA-based IAV entry inhibitors, which may provide a new choice for controlling future influenza pandemics.This publication has 95 references indexed in Scilit:
- Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferretsNature, 2012
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A virusesProceedings of the National Academy of Sciences of the United States of America, 2010
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusionProceedings of the National Academy of Sciences of the United States of America, 2008
- A Cell-penetrating Helical Peptide as a Potential HIV-1 InhibitorJournal of Molecular Biology, 2008
- Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusionVirology, 2008
- Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virusProceedings of the National Academy of Sciences of the United States of America, 2007
- H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypesVirology, 2004
- Novel Therapies Based on Mechanisms of HIV-1 Cell EntryNew England Journal of Medicine, 2003
- Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolutionNature, 1981